References
- Bonne C, Raynaud J P. Methyltrienolone, a specific ligand for cellular androgen receptors. Steroids 1975; 26: 227
- Cowan R A., Cowan S K., Grant J K. Binding of methyltrienolone (R1881) to a progesterone receptor-like component of human prostatic cytosol. J Endocrinol 1977; 74: 281
- Friberg L G., Kullander S, Persijin J P., Korsten C B. On receptors for estrogens and androgens (DHT) in human endometrial carcinoma and ovarian tumours. Acta Ob-stet Gynecol Scand 1978; 57: 261
- Hansson V, Larsen J, Reusch E. Physico-chemical properties of the 5α-dihydrotestosterone binding protein in human male serum. Steroids 1973; 20: 555
- Jänne O, Kauppila A, Kontula K, Syryälä P., Vihko R. Female sex steroid receptors in normal, hyperplastic and carcinomatous endometrium. The relationship to serum steroid hormones and gonadotropins and changes during medroxyprogesterone acetate administration. Int J Cancer 1979; 24: 545
- Kato J, Onouchi T. Specific progesterone receptors in the hypothalamus and anterior hypophysis of the rat. Endocrinology 1977; 101: 270
- Kato J, Onouchi T, Ueda K, Arai K, Okinaga S, Kubo H, Mori H, Seto T. Androgen- and progestin receptors in human endometrial carcinomas. Asia-Oceanic J Obst Gynecol 1982; 82: 169
- Korenman S G., Dukes B A. Specific estrogen binding by the cytoplasm of human breast carcinoma. J Clin En-docrinol Metab 1970; 30: 639
- Lowry O H., Rosebrough N J., Farr A L., Randall R J. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265
- MacLaughlin D T., Richardson G S. Progesterone binding by normal and abnormal human endometrium. J Clin Endocrinol Metab 1976; 42: 667
- Martin J D., Hähnel R. Oestrogen receptor studies in carcinoma of the endometrium, carcinoma of the uterine cervix and other gynaecological malignancies. Aust NZ J Obstet Gynecol 1978; 18: 55
- Martin P M., Rolland P H., Gammere M, Serment H, Toga M. Estradiol and progesterone receptors in normal and neoplastic endometrium: Correlations between receptors, histopathological examinations and clinical responses under progestin theraphy. Int J Cancer 1979; 23: 321
- McCarthy K S., Barton T K., Fetter B F., Creasman W T. Correlation of estrogen and progesterone receptors with histological differentiation in endometrial adeno-carcinoma. Obstet Gynecol 1980; 55: 363
- McGuire W L. Quantitation of estrogen receptors in mammary carcinoma. Methods in Enzymology, O'Malley, Hardman. Hormone Action. 1975; vol. 36: 248
- Mobbs B G., Johnson I E., Connolly J G. In vitro assay of androgen binding by human prostate. J Steroid Bio-chem 1975; 6: 453
- Pollow K, Lubbert H, Boquoi E, Kreuzer G, Pollow B. Characterization and comparison of receptors for 17β-estradiol and progesterone in human proliferative endometrium and endometrial carcinoma. Endocrinology 1975; 96: 319
- Poulsen H E., Taylor C W., Sobin L H. Histological typing of female genital tract tumours. International Histological Classification of Tumours. World Health Organization, Geneva 1975, No. 13
- Scatchard G. The attractions of proteins for small molecules and ions. Ann NY Acad Sci 1949; 51: 660
- Young P CM, Ehrlich C E., Cleary R E. Progesterone binding in human endometrial carcinomas. Am J Obstet Gynecol 1976; 125: 353
- Zava D T., Landau B, Horwitz K B., McGuire W L. Androgen receptor assay with 3H-methyltrienolone (R1881) in the presence of progesterone receptors. Endocrinology 1979; 10: 1007